Advanced search
Start date
Betweenand

Strategies towards the N-glycosylation of indolocarbazole alkaloids and interaction with model cell membranes

Abstract

This Project is aimed at synthesizing compounds from the indolocarbazole family, which are expected to be potent therapeutic agents against cancer, to be used in experiments that simulate the interaction with model membranes made with Langmuir monolayers. Indolocarbazoles (ICZs) have various biological activities, but the greatest interest is focused on compounds that possess antitumor and neuroprotective properties. Compounds whose basic structure is the pyrroloindolocarbazole system with one N-glycosidic bond, such as rebeccamycin, act by DNA topoisomerase I inhibition (attractive target for cancer chemotherapy), whereas those with two N-glycosidic bonds, e.g. staurosporine, are mainly protein kinase C (PKC) inhibitors. In general, the indolocarbazole acceptor is a weaker nucleophile than the bis(indoly1)-maleimide or indole acceptor, which limits the direct application of many established glycosylation methodologies to the indolocarbazole aglycones. In the work proposed here, two stauroporine derivatives, K-252c and K-252d, will be synthesized in gram scale upon exploiting the expertise of the invited researcher. So far, only few derivatives have been achieved by the modification around the ICZ and carbohydrate skeleton. This proposal will be the first of its kind wherein totally diverse ICZ analogues will be achieved. The compounds synthesized will then be used in Langmuir monolayer experiments by other members of the Polymer Group. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)